vs
赫氏（HXL）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是赫氏的1.2倍（$622.0M vs $501.5M），Royalty Pharma plc净利率更高（34.4% vs 7.4%，领先27.0%），赫氏同比增速更快（9.9% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 0.1%）
赫氏是总部位于美国康涅狄格州斯坦福德的上市工业材料企业，专注于结构材料的研发与生产，由加州增强塑料公司、汽巴复合材料业务、赫克力士复合材料产品部门合并组建。其产品覆盖商用、军工、休闲等市场，广泛应用于军民飞机、航天运载火箭、卫星、风电叶片、运动器材等领域。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
HXL vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$501.5M
营收增速更快
HXL
高出5.1%
4.8%
净利率更高
RPRX
高出27.0%
7.4%
两年增速更快
RPRX
近两年复合增速
0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $501.5M | $622.0M |
| 净利润 | $37.2M | $214.2M |
| 毛利率 | 26.9% | — |
| 营业利润率 | 11.5% | 62.4% |
| 净利率 | 7.4% | 34.4% |
| 营收同比 | 9.9% | 4.8% |
| 净利润同比 | 28.7% | 2.9% |
| 每股收益（稀释后） | $0.49 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HXLRPRX
| Q1 26 | $501.5M | — | ||
| Q4 25 | $491.3M | $622.0M | ||
| Q3 25 | $456.2M | $609.3M | ||
| Q2 25 | $489.9M | $578.7M | ||
| Q1 25 | $456.5M | $568.2M | ||
| Q4 24 | $473.8M | $593.6M | ||
| Q3 24 | $456.5M | $564.7M | ||
| Q2 24 | $500.4M | $537.3M |
净利润HXLRPRX
| Q1 26 | $37.2M | — | ||
| Q4 25 | $46.4M | $214.2M | ||
| Q3 25 | $20.6M | $288.2M | ||
| Q2 25 | $13.5M | $30.2M | ||
| Q1 25 | $28.9M | $238.3M | ||
| Q4 24 | $5.8M | $208.2M | ||
| Q3 24 | $39.8M | $544.0M | ||
| Q2 24 | $50.0M | $102.0M |
毛利率HXLRPRX
| Q1 26 | 26.9% | — | ||
| Q4 25 | 24.6% | — | ||
| Q3 25 | 21.9% | — | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 22.4% | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 25.3% | — |
营业利润率HXLRPRX
| Q1 26 | 11.5% | — | ||
| Q4 25 | 12.5% | 62.4% | ||
| Q3 25 | 7.9% | 70.1% | ||
| Q2 25 | 6.1% | 36.3% | ||
| Q1 25 | 9.7% | 94.0% | ||
| Q4 24 | 1.9% | 60.9% | ||
| Q3 24 | 11.5% | — | ||
| Q2 24 | 14.3% | 50.2% |
净利率HXLRPRX
| Q1 26 | 7.4% | — | ||
| Q4 25 | 9.4% | 34.4% | ||
| Q3 25 | 4.5% | 47.3% | ||
| Q2 25 | 2.8% | 5.2% | ||
| Q1 25 | 6.3% | 41.9% | ||
| Q4 24 | 1.2% | 35.1% | ||
| Q3 24 | 8.7% | 96.3% | ||
| Q2 24 | 10.0% | 19.0% |
每股收益（稀释后）HXLRPRX
| Q1 26 | $0.49 | — | ||
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $54.1M | $618.7M |
| 总债务越低越好 | $998.1M | $9.0B |
| 股东权益账面价值 | $1.3B | $9.7B |
| 总资产 | $2.7B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.79× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资HXLRPRX
| Q1 26 | $54.1M | — | ||
| Q4 25 | $71.0M | $618.7M | ||
| Q3 25 | $90.5M | $938.9M | ||
| Q2 25 | $77.2M | $631.9M | ||
| Q1 25 | $89.2M | $1.1B | ||
| Q4 24 | $125.4M | $929.0M | ||
| Q3 24 | $98.2M | $950.1M | ||
| Q2 24 | $75.4M | $1.8B |
总债务HXLRPRX
| Q1 26 | $998.1M | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益HXLRPRX
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $9.7B | ||
| Q3 25 | $1.6B | $9.6B | ||
| Q2 25 | $1.6B | $9.5B | ||
| Q1 25 | $1.5B | $9.8B | ||
| Q4 24 | $1.5B | $10.3B | ||
| Q3 24 | $1.6B | $10.3B | ||
| Q2 24 | $1.6B | $9.8B |
总资产HXLRPRX
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $19.6B | ||
| Q3 25 | $2.8B | $19.3B | ||
| Q2 25 | $2.8B | $18.3B | ||
| Q1 25 | $2.8B | $17.6B | ||
| Q4 24 | $2.7B | $18.2B | ||
| Q3 24 | $2.9B | $18.0B | ||
| Q2 24 | $2.8B | $17.7B |
负债/权益比HXLRPRX
| Q1 26 | 0.79× | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 3.2% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流HXLRPRX
| Q1 26 | — | — | ||
| Q4 25 | $125.5M | $827.1M | ||
| Q3 25 | $110.2M | $702.6M | ||
| Q2 25 | $23.3M | $364.0M | ||
| Q1 25 | $-28.5M | $596.1M | ||
| Q4 24 | $162.6M | $742.5M | ||
| Q3 24 | $90.1M | $703.6M | ||
| Q2 24 | $44.2M | $658.2M |
自由现金流HXLRPRX
| Q1 26 | — | — | ||
| Q4 25 | $107.3M | — | ||
| Q3 25 | $96.5M | — | ||
| Q2 25 | $8.0M | — | ||
| Q1 25 | $-54.6M | — | ||
| Q4 24 | $144.0M | — | ||
| Q3 24 | $73.3M | — | ||
| Q2 24 | $21.3M | — |
自由现金流率HXLRPRX
| Q1 26 | — | — | ||
| Q4 25 | 21.8% | — | ||
| Q3 25 | 21.2% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | -12.0% | — | ||
| Q4 24 | 30.4% | — | ||
| Q3 24 | 16.1% | — | ||
| Q2 24 | 4.3% | — |
资本支出强度HXLRPRX
| Q1 26 | 3.2% | — | ||
| Q4 25 | 3.7% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 4.6% | — |
现金转化率HXLRPRX
| Q1 26 | — | — | ||
| Q4 25 | 2.70× | 3.86× | ||
| Q3 25 | 5.35× | 2.44× | ||
| Q2 25 | 1.73× | 12.06× | ||
| Q1 25 | -0.99× | 2.50× | ||
| Q4 24 | 28.03× | 3.57× | ||
| Q3 24 | 2.26× | 1.29× | ||
| Q2 24 | 0.88× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HXL
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
